Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADAP |
---|---|---|
09:32 ET | 11471 | 2.425 |
09:36 ET | 1000 | 2.43 |
09:38 ET | 1400 | 2.41 |
09:39 ET | 2139 | 2.39 |
09:41 ET | 12973 | 2.42 |
09:43 ET | 4798 | 2.38 |
09:45 ET | 1949 | 2.38 |
09:48 ET | 6624 | 2.42 |
09:50 ET | 600 | 2.42 |
09:52 ET | 1200 | 2.39 |
09:57 ET | 658 | 2.42 |
09:59 ET | 800 | 2.41 |
10:03 ET | 946 | 2.406 |
10:08 ET | 500 | 2.4068 |
10:10 ET | 700 | 2.3993 |
10:14 ET | 2500 | 2.3949 |
10:15 ET | 1100 | 2.4077 |
10:17 ET | 100 | 2.38 |
10:19 ET | 1000 | 2.37 |
10:21 ET | 350 | 2.365 |
10:24 ET | 6640 | 2.352 |
10:26 ET | 200 | 2.37 |
10:30 ET | 200 | 2.38 |
10:33 ET | 800 | 2.4 |
10:35 ET | 100 | 2.4 |
10:37 ET | 100 | 2.405 |
10:39 ET | 220 | 2.3942 |
10:42 ET | 300 | 2.42 |
10:46 ET | 1001 | 2.425 |
10:48 ET | 800 | 2.44 |
10:50 ET | 173 | 2.44 |
10:51 ET | 2032 | 2.42 |
10:53 ET | 600 | 2.43 |
10:55 ET | 4212 | 2.46 |
10:57 ET | 1400 | 2.47 |
11:00 ET | 2812 | 2.45 |
11:02 ET | 525 | 2.4657 |
11:04 ET | 12300 | 2.5299 |
11:06 ET | 6171 | 2.515 |
11:08 ET | 1000 | 2.5299 |
11:09 ET | 8843 | 2.5 |
11:11 ET | 1000 | 2.507 |
11:13 ET | 200 | 2.5001 |
11:15 ET | 4508 | 2.47 |
11:18 ET | 200 | 2.477 |
11:22 ET | 100 | 2.47 |
11:24 ET | 200 | 2.46 |
11:27 ET | 1413 | 2.49 |
11:31 ET | 800 | 2.49 |
11:33 ET | 5700 | 2.5 |
11:36 ET | 1449 | 2.51 |
11:38 ET | 14579 | 2.46 |
11:40 ET | 2200 | 2.465 |
11:42 ET | 318 | 2.47 |
11:45 ET | 1428 | 2.47 |
11:47 ET | 600 | 2.48 |
11:49 ET | 100 | 2.48 |
11:54 ET | 100 | 2.48 |
11:58 ET | 100 | 2.48 |
12:00 ET | 1900 | 2.4688 |
12:12 ET | 200 | 2.455 |
12:21 ET | 100 | 2.455 |
12:23 ET | 100 | 2.44 |
12:27 ET | 100 | 2.4552 |
12:30 ET | 5285 | 2.44 |
12:32 ET | 500 | 2.44 |
12:34 ET | 100 | 2.45 |
12:36 ET | 100 | 2.45 |
12:38 ET | 674 | 2.4594 |
12:39 ET | 5526 | 2.46 |
12:50 ET | 647 | 2.46 |
12:52 ET | 9341 | 2.45 |
12:54 ET | 216 | 2.45 |
12:56 ET | 100 | 2.455 |
12:59 ET | 100 | 2.47 |
01:01 ET | 100 | 2.47 |
01:03 ET | 100 | 2.455 |
01:06 ET | 400 | 2.4442 |
01:08 ET | 149 | 2.4466 |
01:10 ET | 100 | 2.455 |
01:12 ET | 500 | 2.47 |
01:14 ET | 1100 | 2.46 |
01:21 ET | 6636 | 2.45 |
01:24 ET | 200 | 2.44 |
01:26 ET | 3366 | 2.42 |
01:28 ET | 4262 | 2.415 |
01:30 ET | 300 | 2.42 |
01:32 ET | 200 | 2.415 |
01:33 ET | 100 | 2.415 |
01:35 ET | 200 | 2.415 |
01:37 ET | 200 | 2.4186 |
01:39 ET | 378 | 2.415 |
01:46 ET | 257 | 2.415 |
01:48 ET | 100 | 2.415 |
01:50 ET | 100 | 2.415 |
01:51 ET | 408 | 2.415 |
01:55 ET | 1635 | 2.41 |
01:57 ET | 511 | 2.42 |
02:00 ET | 100 | 2.42 |
02:02 ET | 200 | 2.415 |
02:06 ET | 524 | 2.415 |
02:08 ET | 315 | 2.415 |
02:09 ET | 337 | 2.4153 |
02:11 ET | 512 | 2.42 |
02:13 ET | 200 | 2.42 |
02:15 ET | 14955 | 2.405 |
02:18 ET | 400 | 2.405 |
02:22 ET | 2389 | 2.415 |
02:29 ET | 1696 | 2.4127 |
02:31 ET | 739 | 2.42 |
02:36 ET | 100 | 2.42 |
02:38 ET | 200 | 2.42 |
02:40 ET | 7122 | 2.395 |
02:42 ET | 100 | 2.395 |
02:44 ET | 300 | 2.3952 |
02:45 ET | 1745 | 2.4 |
02:49 ET | 841 | 2.405 |
02:54 ET | 100 | 2.39 |
03:00 ET | 905 | 2.405 |
03:02 ET | 100 | 2.4 |
03:03 ET | 100 | 2.39 |
03:09 ET | 200 | 2.39 |
03:16 ET | 200 | 2.405 |
03:18 ET | 100 | 2.4125 |
03:20 ET | 800 | 2.405 |
03:23 ET | 800 | 2.39 |
03:27 ET | 650 | 2.405 |
03:30 ET | 200 | 2.405 |
03:32 ET | 712 | 2.41 |
03:34 ET | 1164 | 2.425 |
03:36 ET | 400 | 2.425 |
03:38 ET | 4008 | 2.415 |
03:39 ET | 971 | 2.415 |
03:41 ET | 1400 | 2.415 |
03:43 ET | 1625 | 2.42 |
03:45 ET | 300 | 2.415 |
03:48 ET | 900 | 2.41 |
03:50 ET | 5100 | 2.415 |
03:52 ET | 1323 | 2.43 |
03:54 ET | 2951 | 2.41 |
03:56 ET | 4615 | 2.4 |
03:57 ET | 14336 | 2.41 |
03:59 ET | 15479 | 2.41 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adaptimmune Therapeutics PLC | 375.8M | -2.2x | --- |
Absci Corp | 390.0M | -3.5x | --- |
Zomedica Corp | 377.3M | -19.7x | --- |
Arbutus Biopharma Corp | 374.9M | -4.2x | --- |
Humacyte Inc | 359.5M | -18.9x | --- |
Entrada Therapeutics Inc | 395.5M | 0.0x | --- |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. It develops T-cell therapies for solid tumors and have reported clinical responses (per RECIST 1.1) in seven solid tumor indications. Its platform enables to identify cancer targets, find and develop cell therapy candidates active against those targets and produce therapeutic candidates for administration to patients. Its cell therapy candidates include Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cells, which use genetically engineered T-cell receptors; Tumor Infiltrating Lymphocytes (TiLs) where a patient’s own T-cells are co-administered with its next generation technology, and HLA-independent TCRs (HiTs) where surface proteins are targeted independently of the peptide-HLA complex. Its clinical trials include Spearhead-1 Phase II trial with afamitres gene autoleucel; Surpass Phase I Trial with ADP-A2M4CD8, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $375.8M |
---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 163.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.81 |
EPS | $-1.12 |
Book Value | $1.32 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 32.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,523.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.